Jackson Scott Thomas has filed 20 insider transactions across 4 companies since May 2023.
Most recent transaction: a disposition of 15021 shares of Mural Oncology plc ($MURA) on December 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | D | Stock Option (right to buy) | 15021 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.09% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | D | Stock Option (right to buy) | 8637 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.05% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | D | Stock Option (right to buy) | 8462 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.05% |
| June 12, 2025 | Spero Therapeutics, Inc. | $SPRO | Jackson Scott Thomas | Not found | A | Common Stock | 20000 | $0.00 | 75,000.0000 | 55,900,641 | 36.36% | 0.04% |
| June 11, 2025 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | A | Stock Option (right to buy) | 8637 | $0.00 | 8,637.0000 | 17,228,291 | 9999.99% | 0.05% |
| May 20, 2025 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | M | Common Stock | 6500 | $0.00 | 11,000.0000 | 62,621,185 | 144.44% | 0.01% |
| May 21, 2025 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 62,621,185 | 9999.99% | 0.04% |
| May 21, 2025 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 3750 | $0.00 | 3,750.0000 | 62,621,185 | 9999.99% | 0.01% |
| May 20, 2025 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | M | Restricted Stock Unit | 6500 | $0.00 | 0.0000 | 62,621,185 | 100.00% | 0.01% |
| May 30, 2024 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | A | Stock Option (right to buy) | 8462 | $0.00 | 8,462.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Mural Oncology plc | $MURA | Jackson Scott Thomas | Not found | A | Stock Option (right to buy) | 8462 | $3.35 | 8,462.0000 | 0 | 9999.99% | 0.00% |
| May 29, 2024 | Spero Therapeutics, Inc. | $SPRO | Jackson Scott Thomas | Not found | A | Common Stock | 20000 | $0.00 | 55,000.0000 | 0 | 57.14% | 0.00% |
| May 21, 2024 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 6500 | $0.00 | 6,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 21, 2024 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 16500 | $0.00 | 16,500.0000 | 61,929,198 | 9999.99% | 0.03% |
| May 20, 2024 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | M | Restricted Stock Unit | 4500 | $0.00 | 0.0000 | 61,929,198 | 100.00% | 0.01% |
| May 20, 2024 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | M | Common Stock | 4500 | $0.00 | 4,500.0000 | 61,929,198 | 9999.99% | 0.01% |
| May 1, 2024 | CRESCENT BIOPHARMA, INC. | $CBIO | Jackson Scott Thomas | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 5, 2023 | Spero Therapeutics, Inc. | $SPRO | Jackson Scott Thomas | Not found | A | Common Stock | 20000 | $0.00 | 35,000.0000 | 0 | 133.33% | 0.00% |
| May 31, 2023 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 61,433,124 | 9999.99% | 0.03% |
| May 31, 2023 | MACROGENICS INC | $MGNX | Jackson Scott Thomas | Director | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 61,433,124 | 9999.99% | 0.01% |